Dual‐Mode Hybrid Discharge Plasma‐Activated Injectable Hydrosol for Enhanced Immunotherapeutic Cancer Therapy (Adv. Healthcare Mater. 5/2026)

Advanced Healthcare Materials 2026 Open access

Read full text
Authors: Zewei Wang, Xixi Jing, Danqi Zhang, Zimu Yu, Hao Zhang, Dingxin Liu, Jishen Zhang, Yongping Shao, Mingzhe Rong, Maksudbek Yusupov, Francesco Tampieri, Paul K Chu
DOI: 10.1002/adhm.70663
Cited by: 1

Abstract

Cancer Adjuvant Therapy In the Research Article (DOI: 10.1002/adhm.202502779), Hao Zhang and co-workers systematically delineate an oncotherapeutic strategy, which activates sodium alginate hydrosols by dual-mode hybrid discharge plasma, enabling direct tumor-cell clearance while robustly inducing immunogenic cell death to initiate antitumor immune responses, demonstrating its translational potential as an adjuvant cancer therapy.

Fields of Study & Subjects

Plasma Applications and Diagnostics Surface Modification and Superhydrophobicity Laser Applications in Dentistry and Medicine

Publication details

Journal / source
Advanced Healthcare Materials
Publisher
Wiley
Volume
15
Issue
5
Publication date
1 February 2026
Language
EN